Bartter Syndrome
Bartter Syndrome
Bartter Syndrome
C. W. WANG
Medical Registrar, Department of Medicine, Auckiand Hospital, Atickiand, NLI
1. J. SIMPSON
Senior Lecturer in Medicine, Departmenf of Medicine, AucKiand Hospital, Atickiand, NZ
Abstract:
A 28-year-old male presented with profound hypokalemia and was found to have a variant of
Bartter’s syndrome with nephrocalcinosis, hypercalciuria, normal distal fractional reabsorption
of chloride and normal sodium delivery to the distal tubule. (Aust NZ J Med 1989; 19: 58-60.)
Key words: Bartter’s syndrome, hypokalemia, nephrocalcinosis, juxtaglomerular apparatus hyperplasia,
hypercalciuria, prostaglandin synthetase inhibitor.
INTRODUCTION no relevant family history. His growth was normal and puberty
Bartter’s syndrome, first described in 1962’ is included had not been delayed.
in the differential diagnosis of renal potassium loss with He was slim, of average stature, well-nourished weighing 69
hyperchloruria. Characteristic findings of this syndrome kg and normally mobile. The blood pressure was 120170 mmHg
and there was no postural hypotension, muscle tenderness or
include hypokalemic alkalosis, hyperreninemia,
iveakness demonstrable. The serum potassium was 1.2 mmolil
normotension and juxtaglomerular apparatus hyper- and serum magnesium 0.6 mmol/l. Chloride and phosphate levels
plasia. The pathogenesis of this syndrome is uncertain were also reduced and there was mild impairment of his renal
but relates to renal transport defects in either the proximal function with a urea of 8.7 nimol/l, creatinine 0.10 mmol/l and
or distal tubule, or both. Its treatment is difficult but creatinine clearance of 0.89 nil/s. The urine calcium excretion
improvement in serum potassium levels may be achieved ranged from 11 to 40 mmoV24 h. The very high excretion rates
with prostaglandin synthetase inhibitors, angiotensin occurred during IV replacement therapy but were persistently
converting-enzyme inhibitors and potassium-sparing elevated at other times. Serum calcium and parathyroid hormone
diuretics. levels were normal. The serum bicarbonate level was high normal
(range 3 1 to 38 mmol/l). An arterial blood gas sample was also
We report a variant of Bartter’s syndrome with normal (PO, 14 kPa, PCO, 4.6 kPa). The ECG reflected his
profound h ypokalemia, hypercalciuria and nephrocalci- hypokalemia with generalised T wave flattening, downward
nosis. These findings are similar to those in the children sloping ST segments and the presence of ‘u’ waves.
described by McCredie et al.* Clearance studies after an Urinary potassium losses were high, up to 1200 mmo1/24 h,
oral water load did not demonstrate a defect in either as were chloride losses of up to 900 mmo1/24 h (during IV
proximal or distal tubular sodium reabsorption. therapy). Screening of urine for diuretics’ gave consistently
negative results over his four weeks in hospital. The resting
plasma renin level was markedly elevated at 12.9 ng/ml/h (n
CASE REPORT I . 1 f0.53) although plasma and urinary aldosterone levels were
A 28-year-old Caucasian male, born in Australia, was admitted normal. Renal ultrasound (Fig. 1) and intravenous urography
to Auckland hospital with an eight year history of vague musculo- showed widespread bilateral medullary nephrocalcinosis, the
skeletal and abdominal pains, polydipsia, a one month history kidneys being otherwise normal in size and architecture. A
of depressive symptoms and three days of lethargy and weakness. percutaneous renal biopsy demonstrated juxtaglomerular
His general practitioner had found a serum potassium o f apparatus hyperplasia and no specific tubular changes (Fig. 2).
1.9 mmol/l. He denied diuretic or laxative use but had taken An oral water load test“ after two weeks potassium repletion
several body building remedies including ‘Body Bulk‘, ‘Natural (Table 1) showed that maximum free water clearance and
Balance’, ginseng and multivitamins. None of these contained maximum urinary dilution tended to be low but were not signifi-
components known to cause hypokalemia. He gabe a long history cantly below that of published normal controls. Defective
of polyuria and regularly consumed in cxcess of two litres of fractional distal chloride reabsorption (“H20/(‘H20 + CCI)), or
water daily. There was no history of vomiting or diarrhoea and increased sodium delivery to the distal tubule ((:H,O +(”a)
Reprinf requests to: Dr I . J . Simpson, Department of Medicine, Auckland Hospital, Private Hag, Auckland.
58 Aust NZ J Med 1989; 19 WANG AND SIMPSON
Figure I: liltrasound of left kidney with dense echogenic
renal pyramids as shown by arrows.
fiigurc 2: Hyperplastic juxtaglomerular apparatus.
Magnification x 750. Bar - 30 M.
could not be demonstrated. Formal testing for an acidification in the English literature,’ the majority presenting in
defect was not completed because the patient vomited the childhood and sometimes involving several family
ammonium chloride. Intravenous and then oral repletion of members.
potassium was commenced together with phosphate and
Although hyperaldosteronism induced by increased
magnesium supplements. There was little improvement in the
patient’s hypokalemia until amiloride, indomethacin and later levels of angiotensin 11 was described in Bartter’s original
enalapril were added. The serum potassium eventually stabilised cases, it is not primarily responsible for the renal
in the range 2.3 to 2.7 mmol/l. potassium loss. As with the patient under discussion,
some may have normal or even reduced aldosterone
DISCUSSION secretion in spite of high levels of plasma renin activity.’
This patient demonstrates an interesting variant of Hypokalemia itself may inhibit aldosterone release by a
Bartter’s syndrome. With no evidence for skin or gastro- direct effect on the adrenal gland. However, since chronic
intestinal electrolyte losses, the syndromes associated with renal potassium loss tends to have an indirect stimulatory
renal potassium wasting are most logically classified in effect on aldosterone secretion, it has been suggested that
terms of the prevailing blood pressure. Our patient was a balance may exist in Bartter’s syndrome resulting in
normotensive, and the consistently high serum bicar- normal aldosterone levels despite marked hypokalemia
bonate in the absence of respiratory acidosis effectively and hyperreninernia.6
excluded renal tubular acidosis. Bartter’s syndrome is associated with the over-
In 1962, Bartter and colleagues’ described two patients production of prostaglandins and it has been controversial
with hypokalemic alkalosis, normal blood pressure or a as to whether this is a primary phenomenon or is
tendency to hypotension, urinary potassium loss, high secondary to the hypokalemia. A reduction in urinary
plasma renin activity and hyperplasia of the renin- excretion of prostaglandin El and prostacyclin F, alpha
producing juxtaglomerular apparatus. By 1980 there had has been achieved with improvement of serum potassium
been more than 100 cases of Bartter’s syndrome reported levels though others have recorded normal prostacyclin
TABLE 1
Clearance Studies After an Oral Water Load* *
v max
(mlimin)
u OSM
(mosmikg) ” c1
MnLmum
(mmolil)
S osm
(mosmikg)
PC’
(mmolil)
CH20
(mlivin)
CNa
(mlimir)
LC1
(mlimln)
‘H20 CNa+
c ~~0
LCr
(mlisec)